BiotechTube
Home/AdaptVac/Prof. Adam Sander
PA

Prof. Adam Sander

CSO, Board Member

AdaptVac

Therapeutic Areas

OncologyInfectious DiseasesImmunological Disorders

AdaptVac Pipeline

DrugIndicationPhase
ABNCoV2COVID-19Phase 3
HER2+ cVLP VaccineHER2-positive Breast CancerPhase 1
cVLP Nipah Virus VaccineNipah Virus InfectionPre-clinical

Leadership Team at AdaptVac

WD
Wian de Jongh
CEO
PM
Prof. Morten Nielsen
COO, Chairman of the Board
DC
Dr. Cyrielle Fougeroux
Team Leader
DL
Dr. Louise Goksøyr
Project Lead
DA
Dr. Allan Rosetzsky
Board Member
View full AdaptVac profile